Wu Dan, Yu Yang, Zheng Haoran, Xiang Ling, Wang Xiaoqing, Zhang Yong, Sun Zhongming, Miao Dandan, Zhou Jinyi, Pan Enchun, Hu Wen
Department of Endocrinology, Huai'an Hospital Affiliated to Xuzhou Medical University and Huai'an Second People's Hospital, Huai'an, Jiangsu, China.
Department of Chronic Disease Prevention and Control, Huai'an City Center for Disease Control and Prevention, Huai'an, China.
Front Endocrinol (Lausanne). 2024 Dec 19;15:1451364. doi: 10.3389/fendo.2024.1451364. eCollection 2024.
To examine the association between the age at onset of diabetes and the risk of all-cause mortality in a population of individuals diagnosed with type 2 diabetes mellitus (T2DM) and to identify risk factors associated with all-cause mortality in young-onset T2DM (YOD) patients in China.
This study utilized a cohort of 9759 patients who were diagnosed with T2DM and who were registered and enrolled in the National Basic Public Health Service Management Program in Qinghe District (now Qingjiangpu District) and Huai'an District, Huai'an City, Jiangsu Province, China. The patients were observed from November 2013 to July 2014, and all-cause mortality data were obtained by comprehensive matching with the Huai'an City Resident Mortality Database as of December 31, 2019. A Cox proportional hazards model was used to compute the hazard ratios (HRs) and their corresponding 95% confidence intervals (95% CIs) for all-cause mortality risk during the follow-up period among patients with varying disease onset ages. Additionally, subgroup analyses were conducted based on sex, age, lifestyle factors, and baseline clinical parameters.
A total of 7572 patients with T2DM, including 2874 men and 4698 women aged 57.9 ± 8.0 years, were ultimately included in the study. 1) At baseline, a greater proportion of YOD patients were engaged in high-intensity activities, had a longer sleep duration, had a longer duration of T2DM, had a family history of T2DM, had microvascular complications (kidney disease, retinopathy, neuropathy, diabetic foot, etc.), and received glucose-lowering treatment. Moreover, patients in the YOD group also had significantly greater baseline HbA1c, FBG, and estimated glomerular filtration rate (eGFR) than did those in the onset at 41-60 years (MD) group and the onset at 61-75 years (SD) group. 2) During the six-year follow-up period, a total of 1057 deaths were documented. After adjusting for confounding factors and utilizing SD as the reference group, the HRs for deaths occurring in the YOD and MD groups were 1.383 (95% CI: 0.717-2.667) and 1.006 (95% CI: 0.763-1.326), respectively. Moreover, the risk of death in the YOD group remained highest in the sensitivity analysis that excluded patients with coronary heart disease at baseline, stroke patients, and patients who died within the first three years of follow-up. 3) Sleep duration was identified as an independent risk factor for mortality in the YOD group, with a notable increase in the risk of all-cause mortality when sleep duration exceeded 9 hours per day.
The risk of all-cause mortality in YOD patients was 1.38 times greater than that in MD and SD patients, and the longer the sleep duration was, the greater the risk of death, especially when sleep duration exceeded 9 hours per day.
探讨2型糖尿病(T2DM)患者糖尿病发病年龄与全因死亡风险之间的关联,并确定中国青年起病T2DM(YOD)患者全因死亡的相关危险因素。
本研究纳入了9759例诊断为T2DM的患者队列,这些患者在中国江苏省淮安市清河区(现清江浦区)和淮安区登记并纳入国家基本公共卫生服务管理项目。对患者进行了2013年11月至2014年7月的观察,并通过与截至2019年12月31日的淮安市居民死亡数据库进行全面匹配获得全因死亡数据。采用Cox比例风险模型计算不同疾病发病年龄患者随访期间全因死亡风险的风险比(HRs)及其相应的95%置信区间(95% CIs)。此外,还根据性别、年龄、生活方式因素和基线临床参数进行了亚组分析。
最终纳入了7572例T2DM患者,其中包括2874例男性和4698例女性,年龄为57.9±8.0岁。1)在基线时,YOD患者中从事高强度活动、睡眠时间较长、T2DM病程较长、有T2DM家族史、有微血管并发症(肾病、视网膜病变、神经病变、糖尿病足等)以及接受降糖治疗的比例更高。此外,YOD组患者的基线糖化血红蛋白(HbA1c)、空腹血糖(FBG)和估算肾小球滤过率(eGFR)也显著高于41 - 60岁起病(MD)组和61 - 75岁起病(SD)组。2)在六年的随访期内,共记录了1057例死亡病例。在调整混杂因素并以SD组作为参照组后,YOD组和MD组死亡的HRs分别为1.383(95% CI:0.717 - 2.667)和1.006(95% CI:0.763 - 1.326)。此外,在排除基线有冠心病患者、中风患者以及随访前三年死亡患者的敏感性分析中,YOD组的死亡风险仍然最高。3)睡眠时间被确定为YOD组死亡的独立危险因素,当睡眠时间超过每天9小时时,全因死亡风险显著增加。
YOD患者的全因死亡风险比MD和SD患者高1.38倍,睡眠时间越长,死亡风险越高,尤其是当睡眠时间超过每天9小时时。